Previous 10 | Next 10 |
Applied DNA Sciences Inc. (NASDAQ:APDN) traded at a new 52-week high today of $20.00. This new high was reached on above average trading volume as 76.6 million shares traded hands, while the average 30-day volume is approximately 94,000 shares. Applied DNA Sciences Inc is a provider of D...
Health Services Contract Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has been awarde...
Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in cell-free, enzymatic DNA production, today announced that CEO Dr. James A. Hayward is invited to present at the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest, on March 28 th - 30 th fro...
Applied DNA Sciences (NASDAQ:APDN) and Spindle Biotech are collaborating for research on simplified high yield mRNA production system. Under the non-binding letter of intent (LOI), the two plan to investigate the feasibility of using Applied DNA's LinearDNATM platform to produce chemically mo...
- Companies Aim to Bring Together LinearDNA™ and Spindle Biotech’s Proprietary Engineered RNA Polymerase to Develop a Next-Generation, Cell-Free mRNA Production Platform - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a ...
Applied DNA Sciences (NASDAQ: APDN) , a leader in polymerase chain reaction (“PCR”)-based DNA manufacturing, has closed on its previously announced registered direct offering. The offering was with an institutional investor and was comprised of 1,496,400 shares of common stock...
Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, announced today that Chief Executive Officer Dr. James A. Hayward will host a virtual fireside chat with the Company's covering analyst...
The shares of life sciences company, Applied DNA Sciences (APDN +7.7%) are rising on Wednesday amid reports that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its unsupervised at-home COVID-19 sample collection kit. Applied DNA (NASDAQ:APDN) curr...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with an institutional investor of 1,496,400 shares of common s...
Applied DNA Sciences (NASDAQ:APDN) has dropped -12.80% pre-market after pricing its share offering. The company entered into a securities purchase agreement with an institutional investor for the sale of 1,496,400 shares of its common stock at $2.80/share. Gross proceeds is estimated to ...
News, Short Squeeze, Breakout and More Instantly...
Applied DNA Sciences Inc. Company Name:
APDN Stock Symbol:
NASDAQ Market:
Applied DNA Sciences Inc. Website:
STONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency (DLA) exercised the first one-year option period of a three-year base contract with two one-year...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability - - Applied DNA Secures Commercial Linea RNAP Quantity Sufficient to Support Anticipated Near-Term Demand - STONY BROOK, NY AND JUPITER, FL / ACCES...